KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Inventory (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 16 years of Change in Inventory data on record, last reported at -$7.7 million in Q4 2025.

  • For Q4 2025, Change in Inventory fell 141.36% year-over-year to -$7.7 million; the TTM value through Dec 2025 reached $86.0 million, up 88.93%, while the annual FY2025 figure was $86.0 million, 88.93% up from the prior year.
  • Change in Inventory reached -$7.7 million in Q4 2025 per JAZZ's latest filing, down from $31.9 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $35.6 million in Q1 2025 and bottomed at -$7.7 million in Q4 2025.
  • Average Change in Inventory over 5 years is $12.2 million, with a median of $8.9 million recorded in 2022.
  • Peak YoY movement for Change in Inventory: soared 1229.42% in 2024, then tumbled 141.36% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $15.0 million in 2021, then plummeted by 105.45% to -$816000.0 in 2022, then soared by 272.06% to $1.4 million in 2023, then skyrocketed by 1229.42% to $18.7 million in 2024, then crashed by 141.36% to -$7.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$7.7 million in Q4 2025, $31.9 million in Q3 2025, and $26.2 million in Q2 2025.